Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Mon, 31.03.2025
Your Family Entertainment AG
Your Family Entertainment AG resolves to issue a convertible bond with a total nominal amount of up to EUR 3,828,297.50Munich, March 31st, 2025 - The Management Board and Supervisory Board of Your Family Entertainment AG (WKN: A161N1, ISIN: DE000A161N14, symbol: RTV) today resolved, based on the authorization resolution of the Annual General Meetin [ … ]
Mon, 31.03.2025
elumeo SE
Ad hoc announcement pursuant to Art. 17 (1) MAR
elumeo SE decides on restructuring program of EUR 5.9 million for 2025 and lowers forecast for 2024
Berlin, 31.3.2025 – The board of directors of elumeo SE (ISIN DE000A11Q059), the leading electronic retailer of gemstone jewelry in Europe, has decided on a package of structural measures in ad [ … ]
Mon, 31.03.2025
TUI AG
Inside Information according to article 17 MAR
Availability of building slots for two new vessels confirmed, being the basis for TUI AG’s re-fleeting of Marella Cruises
The shipbuilder Fincantieri S.p.A. has confirmed building slots for two vessels with delivery availability from FY31 onwards; the order representing a value of exceeding €2 billio [ … ]
Mon, 31.03.2025
Grifols Biotest Holdings GmbH
EQS-WpÜG: Grifols Biotest Holdings GmbH / Tender Offer
Tender Offer / Target company: Biotest AG; Bidder: Grifols Biotest Holdings GmbH
31.03.2025 / 08:43 CET/CEST
Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group.
The bidder is solely [ … ]
Mon, 31.03.2025
Biotest AG
Ad-hoc RELEASE
Announcement according to Article 17 European Market Abuse Regulation (MAR)
Biotest AG: Delisting agreement and announced delisting tender offer
eieich, March 31, 2025: Biotest AG (ISIN DE0005227201, ISIN DE0005227235) has today concluded a delisting agreement with its major shareholder, Grifols, S.A., which holds approximate [ … ]
Mon, 31.03.2025
BioVersys AG
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. March 31, 2025, 7am CET
Important patent around BioVersys’ BV100 drug candidate has been granted, protecting the proprietary rifabutin IV formulation technology in China
BV100 patents have now been granted in over 25 countries, including in US, Europe, UK and China
BioVersys AG (SIX [ … ]
Sat, 29.03.2025
Accentro Real Estate AG
Bondholders, minority shareholder and Management Board of ACCENTRO reach agreement in principle on comprehensive restructuring solution
Berlin, 29 March 2025 – As part of the ongoing restructuring negotiations led by a group of bondholders, which together hold approximately 68% of the EUR 225m outstanding principal amount 2020/2026 bond and 100% [ … ]
Fri, 28.03.2025
Mynaric AG
MUNICH, March 28, 2025 – Mynaric AG (FRA:M0YN) (OTC:MYNAY) (the “Company”) announces that Bulent Altan today has tendered his resignation as Chairman and Member of the Supervisory Board of the Company for personal reasons effective April 1, 2025.
Bulent Altan was elected Chairman of the Supervisory Board of the Company following his election as me [ … ]
Fri, 28.03.2025
PPC Zeus Designated Activity Company
28 March 2025
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF SENIOR NOTEHOLDERS. IF SENIOR NOTEHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD IMMEDIATELY CONSULT THEIR OWN INDEPENDENT PROFESSIONAL ADVISERS AUTHORISED UNDER THE FINANCIAL SERVICES AND MARKETS ACT 2000, AS AMENDED (IF THEY ARE LOCATED IN [ … ]
Fri, 28.03.2025
bet-at-home.com AG
AD-HOC INFORMATION
PUBLICATION OF INSIDER INFORMATION PURSUANT TO ARTICLE 17 OF REGULATION (EU) NO. 596/2014
Annual result for the 2024 financial year / Forecast for the 2025 financial year
The gross betting and gaming revenue of the bet-at-home.com AG Group in the 2024 financial year reached EUR 52,300 thousand (previous year: EUR 46,176 tho [ … ]